Official websites use .gov
A.gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
Alock () orhttps:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Retifanlimab-dlwr injection is used to treat certain types of Merkel cell carcinoma (MCC; a type of skin cancer) and anal cancer (cancer that starts in the anus [the opening at the end of the digestive system]). Retifanlimab-dlwr is in a class of medications called monoclonal antibodies. It works by helping your immune system to slow or stop the growth of cancer cells.
Retifanlimab-dlwr comes as a solution (liquid) to be injected slowly into a vein over 30 minutes by a doctor or nurse. It is given once every 4 weeks for as long as your doctor recommends that you receive treatment.
Retifanlimab-dlwr injection may cause serious reactions during the infusion of the medication. You may be given other medications to treat or help prevent reactions to retifanlimab-dlwr. A doctor or nurse will monitor you carefully while you are receiving the medication. Tell your doctor or nurse immediately if you experience any of the following symptoms during the infusion: chills or shaking, itching, rash, flushing, shortness of breath, wheezing, dizziness, feeling faint, back or neck pain, or fever. Your doctor may need to slow down your infusion or delay or permanently stop your treatment if you experience these side effects.
Your doctor may permanently or temporarily stop your treatment, or treat you with other medications if you experience other side effects. Be sure to tell your doctor how you are feeling during your treatment with retifanlimab-dlwr injection.
You will be given you the Medication Guide. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visithttps://www.fda.gov/Drugs/DrugSafety/ucm085729.htm to obtain the Medication Guide.
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
Unless your doctor tells you otherwise, continue your normal diet.
If you miss an appointment to receive retifanlimab-dlwr injection, call your doctor as soon as possible.
Retifanlimab-dlwr may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (https://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
In case of overdose, call the poison control helpline at1-800-222-1222. Information is also available online athttps://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to retifanlimab-dlwr injection.
Keep a written list of all of the prescription and nonprescription (over-the-counter) medicines, vitamins, minerals, and dietary supplements you are taking. Bring this list with you each time you visit a doctor or if you are admitted to the hospital. You should carry the list with you in case of emergencies.